Dynavax (DVAX) Reports Q3 Loss of $0.24/sh

Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.24), versus ($0.15) reported last year. Revenue for the quarter came in at $108.3 million, versus $13.41 million reported last year.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• SL Green Realty (SLG) PT Raised to $57 at Truist Securities
• X Financial (XYF) Tops Q2 EPS by 438c